| #574 |
Detlef Kalweit |
Clariant Finance (Bvi) Limited |
3 |
| #574 |
Thomas Anders Millward |
Novartis Ag |
3 |
| #574 |
Urs Gehrig |
Elpatronic Ag |
3 |
| #574 |
Lisa Sandford |
Novartis Ag |
3 |
| #574 |
Shibeshih Mitiku Belachew |
Hoffmann-La Roche |
3 |
| #574 |
Nicole Pezous |
Novartis Ag |
3 |
| #574 |
Thomas Schäfer |
Ciba Specialty Chemicals |
3 |
| #574 |
Rolf Studer |
Hoffmann-La Roche |
3 |
| #574 |
Georg Schofberger |
Clariant Finance (Bvi) Limited |
3 |
| #574 |
Roland Zoelper |
Ciba Specialty Chemicals |
3 |
| #574 |
Denise Blum |
Hoffmann-La Roche |
3 |
| #574 |
Rene Fischer |
Basf Se |
3 |
| #574 |
Denis LUTHRINGER |
Hoffmann-La Roche |
3 |
| #574 |
Andreas Weichselberger |
Novartis Ag |
3 |
| #574 |
Margarita Gekkieva |
Novartis Ag |
3 |
| #574 |
Anke DORN |
Hoffmann-La Roche |
3 |
| #574 |
Gregor Welti |
Basilea Pharmaceutica International Ag |
3 |
| #574 |
Ian Jones |
Hoffmann-La Roche |
3 |
| #574 |
Andreas Wilk |
Lawrence Livermore National Security |
3 |
| #574 |
Anaïs Lopez |
Hoffmann-La Roche |
3 |
| #574 |
Irene Puttner |
Novartis Ag |
3 |
| #574 |
Kristin Lindauer |
Novartis Ag |
3 |
| #574 |
Matthias Frech |
Merck |
3 |
| #574 |
Rainer WILCKEN |
Novartis Ag |
3 |
| #574 |
Hans-Jorg Peter |
Huntsman International |
3 |
| #574 |
Lukas Franciszkiewicz |
— |
3 |
| #574 |
Martin List |
Sandoz Ag |
3 |
| #574 |
Felix Bleuel |
Ciba-Geigy |
3 |
| #574 |
Beat Freiermuth |
Ciba Specialty Chemicals |
3 |
| #574 |
Harald Danigel |
Syngenta Crop Protection Ag |
3 |
| #574 |
Gabriel Porto |
Antares Pharma Ipl Ag |
3 |
| #574 |
Aaldert Molenberg |
— |
3 |
| #574 |
Ulrike Nettekoven |
Solvias Ag |
3 |
| #574 |
Arnold Gloor |
Dsm Ip Assets B.V. |
3 |
| #574 |
Anja Meury |
Dsm Ip Assets B.V. |
3 |
| #574 |
Rolf Hofmann |
Develop Dr. Eisbein Gmbh & |
3 |
| #574 |
Brigitta-Maria Liechty |
Novartis Ag |
3 |
| #574 |
Markus G. Goese |
Dsm Ip Assets B.V. |
3 |
| #574 |
Anne F. Mayer |
Dsm Ip Assets B.V. |
3 |
| #574 |
Therese Cronin |
University of Pennsylvania |
3 |
| #574 |
Bernard Pirard |
Novartis Ag |
3 |
| #574 |
Matthias Loppacher |
— |
3 |
| #574 |
Christoph Niederberger |
— |
3 |
| #574 |
Thomas Clavey |
Dsm Ip Assets B.V. |
3 |
| #574 |
Marcus Meier |
Straumann Holding Ag |
3 |
| #574 |
Leopold Franciscus Wijnandus Vleugels |
Basf Se |
3 |
| #574 |
Edvard Ham |
Huntsman International |
3 |
| #574 |
Rene Schlatter |
Ciba Specialty Chemicals |
3 |
| #574 |
Berthold Schenkel |
Novartis Ag |
3 |
| #574 |
Juergen REINHARDT |
Novartis Ag |
3 |